Ceftazidime-Avibactam Resistance Associated with Increased
Anti-Bacterial Agents
/ pharmacology
Azabicyclo Compounds
/ pharmacology
Bacterial Proteins
/ genetics
Ceftazidime
/ pharmacology
DNA Transposable Elements
/ genetics
Drug Combinations
Drug Resistance, Multiple, Bacterial
/ genetics
Escherichia coli
/ genetics
Gene Dosage
/ genetics
Genome, Bacterial
/ genetics
Humans
Kidney Transplantation
/ adverse effects
Klebsiella Infections
/ drug therapy
Klebsiella pneumoniae
/ drug effects
Microbial Sensitivity Tests
Plasmids
/ genetics
Porins
/ genetics
Whole Genome Sequencing
beta-Lactamase Inhibitors
/ pharmacology
beta-Lactamases
/ genetics
CAZ-AVI
KPC
Tn4401
avibactam
carbapenem-resistant Enterobacterales
carbapenemase
double copy
porin alterations
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
24 03 2020
24 03 2020
Historique:
received:
04
09
2019
accepted:
12
01
2020
pubmed:
23
1
2020
medline:
12
1
2021
entrez:
23
1
2020
Statut:
epublish
Résumé
This study reports on the characterization of two ceftazidime-avibactam (CZA)-resistant KPC-producing
Identifiants
pubmed: 31964792
pii: AAC.01816-19
doi: 10.1128/AAC.01816-19
pmc: PMC7179273
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Azabicyclo Compounds
0
Bacterial Proteins
0
DNA Transposable Elements
0
Drug Combinations
0
OmpK35 porin, Klebsiella pneumoniae
0
OmpK36 protein, Klebsiella pneumoniae
0
Porins
0
avibactam, ceftazidime drug combination
0
beta-Lactamase Inhibitors
0
Ceftazidime
9M416Z9QNR
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
Antimicrob Agents Chemother. 2013 Jan;57(1):410-6
pubmed: 23114762
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29263067
Antimicrob Agents Chemother. 2010 Oct;54(10):4178-84
pubmed: 20660683
Clin Microbiol Infect. 2020 Jan;26(1):124.e1-124.e4
pubmed: 31494252
Euro Surveill. 2013 May 30;18(22):
pubmed: 23787077
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28223379
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Clin Microbiol Infect. 2019 Jun;25(6):763.e5-763.e8
pubmed: 30928562
Microb Genom. 2020 Jan;6(1):
pubmed: 32003322
Antimicrob Agents Chemother. 2014 Oct;58(10):5696-703
pubmed: 25022583
Diagn Microbiol Infect Dis. 2017 Jul;88(3):207-213
pubmed: 28502395
Drugs. 2018 Apr;78(6):675-692
pubmed: 29671219
Nat Commun. 2019 Sep 2;10(1):3957
pubmed: 31477712
Clin Microbiol Infect. 2020 Apr;26(4):516.e1-516.e4
pubmed: 31740422
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29507064
J Med Microbiol. 2018 Mar;67(3):289-295
pubmed: 29458684
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 29038260
Antimicrob Agents Chemother. 2010 Oct;54(10):4493-6
pubmed: 20696875
Trends Microbiol. 2014 Dec;22(12):686-96
pubmed: 25304194
J Intern Med. 2015 May;277(5):528-31
pubmed: 25627464
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28739787
Expert Opin Pharmacother. 2019 Dec;20(17):2169-2184
pubmed: 31500471
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031201
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Antimicrob Chemother. 2018 Mar 1;73(3):664-671
pubmed: 29216350
J Antimicrob Chemother. 2016 Oct;71(10):2824-30
pubmed: 27334661
PLoS One. 2015 Jul 21;10(7):e0133727
pubmed: 26196384
Antimicrob Agents Chemother. 2015 Oct;59(10):6605-7
pubmed: 26195508
J Glob Antimicrob Resist. 2019 Dec 18;:
pubmed: 31863899
Antimicrob Agents Chemother. 2015 Sep;59(9):5340-7
pubmed: 26100713
Nat Microbiol. 2019 Nov;4(11):1919-1929
pubmed: 31358985